Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Employees - 12, CEO - Ronald P. Erickson, Sector - Technology, Country - US, Market Cap -

Altman ZScore(max is 10): -507.19, Piotroski Score(max is 10): 2, Working Capital: $-4959519, Total Assets: $492567, Retained Earnings: $-150723402, EBIT: -10098622, Total Liabilities: $5284766, Revenue: $0

AryaFin Target Price - $-0.92 - Current Price $ - Analyst Target Price $